Screener
Marker Therapeutics, Inc. MRKR Q3 2025 earnings
Reported November 13, 2025 · Before market open
Revenue$1.2MBeat by $509.9K
EPS-$0.12Beat by $0.24
Revenue estimate$723.0K
EPS estimate-$0.36
Next report
Nov 12, 2026 (in 2 months)Revenue estimate$2.1M
EPS estimate-$0.12
Versus estimates
Revenue
Q4 2025$1.1MBeat by $417.9K
Q3 2025$1.2MBeat by $509.9K
Q2 2025$861.2KBeat by $430.6KQ1 2025$349.1KBeat by $174.6KDiluted EPS
FAQ
- When did Marker Therapeutics, Inc. report Q3 2025 earnings?
- Marker Therapeutics, Inc. (MRKR) reported Q3 2025 earnings on November 13, 2025 before market open.
- What were Marker Therapeutics, Inc.'s Q3 2025 revenue and EPS?
- Marker Therapeutics, Inc. reported revenue of $1.2M and eps of $-0.12 for Q3 2025.
- Did Marker Therapeutics, Inc. beat estimates in Q3 2025?
- Revenue beat the consensus estimate of $723.0K by $509.9K. EPS beat the consensus estimate of $-0.36 by $0.24.
- How did Marker Therapeutics, Inc.'s Q3 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 36.0% from $1.9M a year earlier and eps grew 53.8% from $-0.26.
- Where can I find Marker Therapeutics, Inc.'s Q3 2025 SEC filings?
- You can read the 8-K earnings release (0001104659-25-111940) and the 10-Q periodic report (0001104659-25-111502) directly on SEC EDGAR. The filing index links above go to sec.gov.
